Device Trial Radar · NCT00695253
Physician-Sponsored IDE for Talent Endoluminal Spring Graft System in Patients With Abdominal Aortic Aneurysms (AAA)
Last checked: Nov 20, 2026Latest source record: Feb 15, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
49
Actual
Start
Apr 2002
Primary completion
Mar 2013
Study completion Mar 2013
Sponsor
- Lead sponsor
- Rodney A. White, M.D.Academic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jun 11, 2008
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety and effectiveness of the Talent Endoluminal Spring Graft System, an investigational device, to treat abdominal aortic aneurysms (AAA). The treatment population will include patients with an abdominal aortic aneurysm who meet the inclusion/exclusion criteria. All patients in the treatment population will undergo post-procedure follow-up evaluations at one (1), six (6), and 12 months and annually thereafter up to five (5) years post-procedure.
Conditions
- Abdominal Aortic Aneurysms
Interventions
Talent Endoluminal Spring Graft SystemDevice
Endovascular repair for patients with AAA who meet the inclusion criteria for the study
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Successful Exclusion of Abdominal Aortic AneurysmTime frame: From the date of treatment assessed up to 5 years post treatment.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
LAC Harbor-UCLA Medical Center
Torrance, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.